CLOV · NASDAQ
Clover Health Investments (CLOV) Stock Price & Fundamentals
Clover Health Investments (CLOV) closed at $581.43 on Oct 9, 2026, up 0.64% from the previous close of $577.72.
Share price, past year
1Y +47.08%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $581.43 |
| Sep 30, 2026 | $569.76 |
| Aug 31, 2026 | $535.98 |
| Jul 31, 2026 | $485.29 |
| Jun 30, 2026 | $493.64 |
| May 29, 2026 | $483.91 |
| Apr 30, 2026 | $485.98 |
| Mar 31, 2026 | $436.41 |
| Feb 27, 2026 | $389.30 |
| Jan 30, 2026 | $376.44 |
| Dec 31, 2025 | $395.36 |
| Nov 28, 2025 | $388.27 |
| Oct 31, 2025 | $383.76 |
Key statistics
- Market cap
- —
- P/E (TTM)
- 7,267.9
- EPS (TTM)
- $0.08
- Revenue (TTM)
- $2.48B
- Net income (TTM)
- −$18.36M
- Shares outstanding
- —
- Dividend yield
- —
- 52-week range
- $371.96 – $591.49
Financials
Clover Health Investments reported revenue of $1.92B for fiscal 2025, up 40.34% from fiscal 2024.
Clover Health Investments reported a net loss of $85.55M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 7 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $1.92B | +40.3% | −$85.55M | −4.5% | — | −$68.98M |
| FY2024ended Dec 31, 2024 | $1.37B | +8.8% | −$43.01M | −3.1% | — | $33.29M |
| FY2023ended Dec 31, 2023 | $1.26B | +15.0% | −$213.36M | −16.9% | −$0.44 | −$145.25M |
| FY2022ended Dec 31, 2022 | $1.10B | −25.5% | −$339.57M | −31.0% | −$0.71 | −$208.39M |
| FY2021ended Dec 31, 2021 | $1.47B | +118.8% | −$587.76M | −39.9% | −$1.42 | −$283.05M |
| FY2020ended Dec 31, 2020 | $672.89M | +45.6% | −$136.39M | −20.3% | −$1.54 | −$119.19M |
| FY2019ended Dec 31, 2019 | $462.27M | — | −$363.74M | −78.7% | −$4.14 | −$159.90M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $743.17M | $28.00M | $0.05 |
| Q1 FY2026ended Mar 31, 2026 | $749.19M | $27.33M | $0.05 |
| Q4 FY2025ended Dec 31, 2025 | $487.71M | −$49.32M | — |
| Q3 FY2025ended Sep 30, 2025 | $496.65M | −$24.38M | — |
| Q2 FY2025ended Jun 30, 2025 | $477.62M | −$10.58M | −$0.02 |
| Q1 FY2025ended Mar 31, 2025 | $462.33M | −$1.27M | $0.00 |
| Q4 FY2024ended Dec 31, 2024 | $336.96M | −$22.09M | — |
| Q3 FY2024ended Sep 30, 2024 | $330.99M | −$9.16M | — |
Company profile
- Name
- Clover Health Investments, Corp.
- Ticker
- CLOV
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Hospital & Medical Service Plans
- Headquarters
- 30 Montgomery Street, Jersey City, NJ 07302
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001801170
Recent SEC filings
- Sep 24, 2026
- Aug 20, 2026
- Aug 7, 2026
- Aug 5, 2026
- Jul 17, 2026
- Jun 18, 2026
- Jun 16, 2026
- Jun 12, 2026
Frequently asked questions
What is Clover Health Investments's stock price?
Clover Health Investments (CLOV) closed at $581.43 on Oct 9, 2026, up 0.64% from the previous close of $577.72.
How much revenue does Clover Health Investments make?
Clover Health Investments reported revenue of $1.92B for fiscal 2025, up 40.34% from fiscal 2024.
What is CLOV's P/E ratio?
Clover Health Investments's price-to-earnings ratio is 7,267.9, based on trailing twelve-month diluted EPS of $0.08.
Does Clover Health Investments pay a dividend?
Clover Health Investments's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Clover Health Investments, Corp.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 8, 2026. Data sources and disclosures